Systems and methods for distributing continuous glucose data

US2025025046A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2025025046-A1
Application numberUS-202418907363-A
CountryUS
Kind codeA1
Filing dateOct 4, 2024
Priority dateFeb 10, 2015
Publication dateJan 23, 2025
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to systems, devices and methods for receiving biosensor data acquired by a medical device, e.g., relating to glucose concentration values, and controlling the access and distribution of that data. In some embodiments, systems and methods are disclosed for monitoring glucose levels, displaying data relating to glucose values and metabolic health information, and controlling distribution of glucose data between applications executing on a computer, such as a smart phone. In some embodiments, systems and methods are disclosed for controlling access to medical data such as continuously monitored glucose levels, synchronizing health data relating to glucose levels between multiple applications executing on a computer, and/or encrypting data.

First claim

Opening claim text (preview).

What is claimed is: 1 . A method for controlling distribution of data relating to glucose levels between applications executing on a computing device, comprising: receiving, at a mobile computing device, a plurality of data values relating to glucose level monitoring; separating, at a first application operable on the mobile computing device, the plurality of data values into a first set of data and a second set of data according to a predetermined criteria, the first set of data comprising data values restricted from the second set of data; and providing the second set of data to a second application operable on the mobile computing device. 2 . The method of claim 1 , wherein the first application includes a medical device software application that configures the mobile computing device to receive and process glucose data including the data values relating to the glucose level monitoring provided by a continuous glucose monitoring sensor device, and wherein the second application includes a third-party software application. 3 . The method of claim 2 , wherein the third-party software application is configured to provide at least some capabilities different than that of the first application including processing ancillary data and integrating the ancillary data with the glucose data, wherein the ancillary data includes one or more of insulin data, meal data, or exercise data. 4 . The method of claim 2 , wherein the third-party software application is not an approved medical device software application approved by a governmental regulatory institution authorized to regulate medical device technologies. 5 . The method of claim 1 , wherein the plurality of data values are separated into the first set of data and the second set of data based on predetermined data permissions associated with the second application. 6 . The method of claim 1 , wherein the received plurality of data values include continuously generated glucose measurements, and wherein the separating the plurality of data values further includes: averaging the continuously generated glucose measurements over a predetermined interval to produce glucose average values to be in the second set of data. 7 . The method of claim 1 , wherein the received plurality of data values include continuously generated glucose measurements, and wherein the separating the plurality of data values further includes: generating generalized indications of the continuously generated glucose measurements over a predetermined interval to be in the second set of data, wherein a generalized indication is representative of the continuously generated glucose measurements being in one of a predefined low range, a predefined normal range, and a predefined high range. 8 . The method of claim 1 , wherein each of the plurality of data values include an associated timestamp; and the method comprises: determining, by the first application, that a time duration between a current time and the timestamps meets a predetermined amount of delay; and delaying the providing the second set of data to a second application for the predetermined amount of delay. 9 . The method of claim 8 , wherein the delay is between five minutes and three hours. 10 . The method of claim 8 , further comprising: encrypting the second set of data prior to the providing the second set of data to the second application. 11 . The method of claim 1 , wherein the first application is configured to process glucose data associated with a continuous glucose sensor device; and the method further comprising: receiving from a third-party application, at the first application, one or more single glucose measurements acquired from a single-measurement glucose sensor device; analyzing, by the first application, metadata corresponding to the one or more single glucose measurements; and authenticating, by the first application, the one or more single glucose measurements as calibration data for the continuous analyte sensor device. 12 . A method for controlling access to data relating to glucose levels on a mobile computing device, comprising: receiving data relating to glucose levels using a first application operable on a smart phone; encrypting at least a subset of the data; providing the encrypted subset of data to a second application operable on the smart phone; providing the encrypted subset of data to a third application operable on the smart phone via the second application; and providing a key to the third application to decrypt the encrypted subset of data. 13 . The method of claim 12 , wherein the first application includes a medical device software application that configures the mobile computing device to receive and process the data relating to the glucose levels provided by a continuous glucose monitoring sensor device, and wherein one or both of the second application and the third application is a third-party software application. 14 . The method of claim 13 , wherein the third-party software application is configured to provide at least some capabilities different than that of the first application including processing ancillary data and integrating the ancillary data with the glucose data, wherein the ancillary data includes one or more of insulin data, meal data, or exercise data. 15 . The method of claim 13 , wherein the third-party software application is not an approved medical device software application approved by a governmental regulatory institution authorized to regulate medical device technologies. 16 . The method of claim 12 , further comprising: prior to the providing the encrypted subset of data to the second application, separating the data into a first data set of the data and a second data set of the data consisting of the subset according to a predetermined criteria, wherein the first set of data comprises data values restricted from the second set of data. 17 . The method of claim 12 , wherein the received data includes glucose values and an associated timestamp for each glucose value; and the method comprises: determining, by the first application, that a time duration between a current time and the timestamps meets a predetermined amount of delay; and delaying the providing the second set of data to a second application for the predetermined amount of delay. 18 . The method of claim 17 , wherein the delay is between five minutes and three hours. 19 . The method of claim 12 , wherein the second application is provided the key to decrypt the encrypted subset of data. 20 . A medical device software application on a computer-readable medium of a mobile computing device, the medical device software application for managing glucose data received from a glucose sensor, and comprising instructions which, when executed by a processor of the mobile computing device, causes the mobile computing device to: receive one or more glucose measurements generated by the glucose sensor; divide the one or more glucose measurements into a first set of data and a second set of data according to a predetermined criteria, the first set of data comprising data values restricted from the second set of data; and provide the second set of data to a third-party software application operable on the mobile computing device.

Assignees

Inventors

Classifications

  • Protecting access to data via a platform, e.g. using keys or access control rules · CPC title

  • for remote operation · CPC title

  • using visual displays (displays for heart-related electrical signals, e.g. ECG, A61B5/339) · CPC title

  • Monitoring a patient using a global network, e.g. telephone networks, internet · CPC title

  • characterised by the type of physiological signal transmitted · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2025025046A1 cover?
The present disclosure relates to systems, devices and methods for receiving biosensor data acquired by a medical device, e.g., relating to glucose concentration values, and controlling the access and distribution of that data. In some embodiments, systems and methods are disclosed for monitoring glucose levels, displaying data relating to glucose values and metabolic health information, and co…
Who is the assignee on this patent?
Dexcom Inc
What technology area does this patent fall under?
Primary CPC classification A61B5/0002. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jan 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).